Show simple item record

dc.creatorJamee, Mahnaz 
dc.creatorZaki-Dizaji, Majid 
dc.creatorLo, Bernice 
dc.creatorAbolhassani, Hassan 
dc.creatorAghamahdi, Fatemeh 
dc.creatorMosavian, Mehdi 
dc.creatorNademi, Zohreh 
dc.creatorMohammadi, Hamed 
dc.creatorJadidi-Niaragh, Farhad 
dc.creatorRojas, Manuel 
dc.creatorAnaya, Juan-Manuel 
dc.creatorAzizi, Gholamreza 
dc.date.accessioned2020-06-11T13:20:46Z
dc.date.available2020-06-11T13:20:46Z
dc.date.created2020
dc.identifier.issn2213-2201
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/24566
dc.description.abstractBACKGROUND: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome is a rare inborn error of immunity caused by mutations in the forkhead box P3 (FOXP3) gene.OBJECTIVE: In this study, we conducted a systematic review of IPEX and IPEX-like patients to delineate differences in these two major groups.METHODS: The literature search was performed in PubMed, Web of Science and Scopus databases and demographic, clinical, immunologic, and molecular data were compared between IPEX (n= 312) and IPEX-like (n= 98) groups.RESULTS: A total of 459 patients were reported in 148 eligible articles. Major clinical differences between IPEX and IPEX-like patients were observed in rates of pneumonia (11% vs. 31%, p<0.001), bronchiectasis (0.3% vs. 14%, p<0.001), diarrhea (56% vs. 42%, p=0.020), and organomegaly (10% vs. 23%, p=0.001), respectively. Eosinophilia (95% vs. 100%), low regulatory T cell count (68% vs. 50%), and elevated IgE (87% vs. 61%) were the most prominent laboratory findings in IPEX and IPEX-like patients, respectively. In IPEX group, a lower mortality rate was observed among patients receiving HSCT (24%) compared to other patients (43%), p=0.008, however, in IPEX-like group it was not significant (p=0.189).CONCLUSIONS: Patients with IPEX syndrome generally suffer from enteropathy, autoimmunity, dermatitis, eosinophilia, and elevated serum IgE. Despite similarities in their clinical presentations, patients with IPEX-like syndrome are more likely to present CVID-like phenotype such as respiratory tract infections, bronchiectasis, and organomegaly. HSCT is currently the only curative therapy for both IPEX and IPEX-like syndrome and may result in favorable outcome.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofThe journal of allergy and clinical immunology. In practice, ISSN:2213-2201 (2020); pp. -
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.titleClinical, immunological, and genetic features in patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome.
dc.typearticle
dc.publisherElsevier
dc.subject.keywordAutoimmunity
dc.subject.keywordFOXP3
dc.subject.keywordIPEX
dc.subject.keywordIPEX-like
dc.subject.keywordImmunodysregulation
dc.subject.keywordPolyendocrinopathy
dc.subject.keywordX-Linked
dc.subject.keywordand Enteropathy
dc.rights.accesRightsinfo:eu-repo/semantics/closedAccess
dc.type.spaArtículo
dc.rights.accesoBloqueado (Texto referencial)
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doihttps://doi.org/10.1016/j.jaip.2020.04.070
dc.relation.citationTitleThe journal of allergy and clinical immunology. In practice


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record